Stock events for Henry Schein, Inc. (HSIC)
Over the past six months, Henry Schein, Inc.'s stock price has experienced some fluctuations, with a 7.37% decline between September 26, 2024, and September 25, 2025, and a 5.43% decrease over the last year. In Q1 CY2025, the company missed Wall Street's revenue expectations, but beat analyst estimates on non-GAAP profit. In Q2 2025, Henry Schein reported a miss on profit expectations due to reduced demand in its U.S. dental business, but revenue slightly exceeded estimates. Henry Schein also announced a $750 million share repurchase plan in September 2025, and on October 3, 2025, Wall Street Zen upgraded Henry Schein's stock rating to "Buy".
Demand Seasonality affecting Henry Schein, Inc.’s stock price
While specific detailed seasonal patterns for Henry Schein, Inc.'s products and services are not extensively detailed in publicly available information, recent performance indicates a slowdown in demand. In Q2 2025, Henry Schein experienced reduced demand in its U.S. dental business, attributed to high interest rates and a cautious approach by patients towards non-urgent procedures. This suggests that economic factors and consumer behavior can influence demand for Henry Schein's offerings.
Overview of Henry Schein, Inc.’s business
Henry Schein, Inc. is a global distributor of healthcare products and services, primarily serving office-based dental and medical practitioners, operating within the Health Care sector. The company offers dental products and equipment, medical supplies, and technology solutions, including practice management software, e-commerce solutions, financial services, equipment repair, and consulting and education services. In July 2018, Henry Schein and Internet Brands formed a joint venture, Henry Schein One, to deliver integrated dental technology.
HSIC’s Geographic footprint
Henry Schein, Inc. has a significant global presence, with operations in 33 countries and territories and serving practitioners in over 190 countries and regions worldwide. The United States is a major market for the company, accounting for 69.5% of its net sales. The company's headquarters are located in Melville, New York, U.S.
HSIC Corporate Image Assessment
Henry Schein, Inc. maintains a strong brand reputation, having been recognized as one of the World's Most Ethical Companies by Ethisphere for 14 consecutive years, including 2025. In September 2024, Henry Schein was named to FORTUNE® magazine's "Change the World" list for its innovative emergency preparedness and response strategy. Forbes also listed Henry Schein among the "Most Trusted Companies in America" in 2025 within the Health Care Equipment & Services category.
Ownership
Henry Schein, Inc. has a diverse ownership structure, with a significant portion held by institutional investors, ranging from approximately 90.53% to 112.08% of the stock. Major institutional owners include Kohlberg Kravis Roberts & Co. L.P., Vanguard Group Inc, BlackRock, Inc., Artisan Partners Limited Partnership, JPMorgan Chase & Co, State Street Corp, American Century Companies Inc, Invesco Ltd., Fmr Llc, and Palestra Capital Management LLC. KKR Hawaii Holdings LP is noted as the largest individual Henry Schein shareholder.
Ask Our Expert AI Analyst
Price Chart
$63.39